This website uses cookies to measure and enhance the website's performance. More information on cookies, how they are used and ViiV's cookies policy can be found here.


  • Healthcare professionals

    Look at this website as a comprehensive source of information about dolutegravir for healthcare professionals in Belgium and Luxembourg.


    You are now leaving the site

ViiV Healthcare logo

E.R./V.U.: ViiV Healthcare
Site Apollo / Avenue Pascal 2-4-6 / 1300 Wavre / BELGIUM
ViiV Healthcare SPRL/BVBA, Company No. 0818.038.513
Contact 010/ 85 65 00
©2015 ViiV Healthcare group of companies. All rights reserved.
BE/DLG/0028/14(6) - Creation date: May 2016
For Belgium: Please report adverse events to the Belgian Centre for Pharmacovigileance for medecines for Human use (BCPH) of the Federal Agency for Medecines and Health Products (FAMHP) on the following address: or via the 'yellow card' available on the website or to ViiV Healthcare sprl/bvba at the number 010/ 85 65 00
For Luxembourg: Please report adverse events to the Minister of Health of Grand-Duché of Luxembourg (Pharmacy and Drug Division, at fax number +35 2 24795615 or by post) or at Regional Pharmacovigilance Centre of Lorraine (at fax number +33 3 83 32 33 44 or at or to ViiV Healthcare SPRL/BVBA at the number +32 10 85 65 00.